Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Translation01:31

Translation

15.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.5K
Translational Regulation01:29

Translational Regulation

92
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
92
tRNA Activation02:26

tRNA Activation

6.9K
6.9K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

12.2K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

NNMT and the methylation sink: integrating metabolism, epigenetics and immunity in cancer.

BMC medicine·2026
Same author

Association between frailty status and osteomyelitis: A nested case-control study.

PloS one·2026
Same author

Indium-Mediated Glue-Like Interlayer Enables Stable High-Capacity Flexible Sodium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Efficacy of Adding Intravenous Methylprednisolone to Nebulized Budesonide in RSV Pneumonia: Modification by Bacterial Co-Infection - A Retrospective Cohort Study.

Pediatric health, medicine and therapeutics·2026
Same author

Long-term preservation strategy for legume root nodule phenotypes coupled with a comprehensive evaluation method.

BMC plant biology·2026
Same author

Intestinal tuberculosis in a child: a case report.

Frontiers in medicine·2026

相关实验视频

Updated: Sep 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

635

由tRNA修改引起的翻译重编程代表了癌症治疗的新治疗标.

Yan Hu1,2, Ziqi Liu2, Hongke Qu2

  • 1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Wiley interdisciplinary reviews. RNA
|August 18, 2025
PubMed
概括

异常转移RNA (tRNA) 修改破坏了蛋白质合成,推动了瘤的生长. 针对这些修饰的tRNAs为癌症治疗提供了一个有希望的新途径.

关键词:
癌症治疗的治疗方法在tRNA修改过程中.转移RNAs是一种转移RNA.翻译重新编程翻译重新编程

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.6K

相关实验视频

Last Updated: Sep 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

635
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.6K

科学领域:

  • 分子生物学分子生物学
  • 癌症研究 癌症研究
  • 在RNA生物学,RNA生物学.

背景情况:

  • 失调的蛋白质合成,特别是在癌细胞中,支持瘤基因表达和恶性表型.
  • 转移RNAs (tRNAs) 对于蛋白质合成至关重要,它介导基于信使RNA (mRNA) 编码子的氨基酸运输.
  • 受tRNAs影响的异常翻译重编程是疾病进展的标志.

研究的目的:

  • 通过翻译重编程审查将异常tRNA修饰与瘤发生联系在一起的机制.
  • 总结和讨论在癌症治疗中针对tRNA修饰驱动的翻译的临床潜力.

主要方法:

  • 审查关于tRNA修饰,翻译重编程和癌症的现有文献.
  • 分析tRNA的丰度,分裂和解码能力如何受到修改的影响.
  • 探索针对癌症异常翻译的临床策略.

主要成果:

  • 异常的tRNA修改显著影响tRNA丰度,裂变和mRNA解码.
  • 这些tRNA功能的改变有助于翻译重编程,并促进瘤的进展.
  • 特定的tRNA修改越来越被认为是瘤发生的驱动因素.

结论:

  • 异常的tRNA修改是通过翻译重编程对癌症发展的关键贡献者.
  • 针对由tRNA修饰驱动的过度翻译,为癌症治疗提供了一个可行的治疗策略.
  • 对tRNA修饰途径的进一步研究可能会揭示新的癌症生物标志物和药物点.